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 تصلاخلا  
ثحبلا فذه: ن خسارذنا ِذْ فذٓر بٚززكث خٛهثبل خفزؼًEnterotoxigenic E.coli   شٛفحر ٗهػ خٕٚؼًنا بٓيًٕسٔخثبغزسلاا  للاخ ٍي خٕٚهخنا خٛػبًُنا
ضٛجنا بٚلاخنا حزغْ ظٛجضر ميبؼئ ٙئبزنا ٘زْشنا مٛكشزنا ٘ربجزخا. 
 :تٍجهنملا  ىر غًع03  سازث خُٛػ(stool) نا ٍي ٍٛثبصًنا ٗضزًلبٓسلإبث ن ٍٛؼعازًنا دبحناًٙٛهؼزنا رذصنا ٗفشزسً ٙف فزشلأا فغُنا,  حززفنا ٙف
 ٌازٚشحٔ ٌبسَٛ ٘زٓش ٍٛث حذزًًنا3300  وبظَ لبًؼزسبثٔ خٕٚٛحًٕٛكنأ خٚزٓظًنا داربجزخلاا كفٔ دلاشؼنا ذصخشAPI 20 E.  ىرذكأزنا  ٍي
 ٗهػ بٓزٛهثبلطبزَإ ربجزخا للاخ ٍي خٕٚؼًنا وًٕسنا  غٛضزنا رأفناSuckling Mice Assay (SMA) نا ٍػ ٘زحزهن دلاشؼنا غًٛغنٕ٘ؼًنا ىس  ذثبضنا
حرازحنبث سلاص زٛضحر ىر شٛح .عإَأ ٗمًُنا حرازحنبث ذثبضنا ٕ٘ؼًنا ىسنأ ,وبخنا ٕ٘ؼًنا ىسنأ ,حرازحنبث خنٕزمًنا بٚززكجنا( دبُٛغٛزَلاا ٍي   بٛئشع 
ETECST )ٙف بْربجزخا ىر ٙزنأ تَارلأا  خٚزجزخًنا ٖٕزسًنا ٗهػا٘سبٓغن)وذنا(خٛطبخًنا خغسَلأأ خٚدٔذنا حذئاشنا(ُٙصلاأ )٘زشػ. مٛهحزنا ٘زعأ
ٙئبصحلإا .ُٕ٘ؼي قزف ملا ربجزخبث 
 :حئاتنلا خٕٚؼًنا وًٕسهن خغزًُنا ٌٕنٕمنا بٚززكث خجسَ ذَبك 33 غلإثٔ %6 ذُٛث بًٛف دلاشػٌا خٛػبًُنا ةربغزنا ظئبزَ  خجسَ ٙف خُٕٚؼي حدبٚس نبُْ
ٙئبزنا ٘زْشنا مٛكشزنا (حرازحنبث خنٕزمًنا بٚززكجنبث غٚزغزنا ذُػ13.0% ,7..4%  ٔ10.3%( حزطٛسنا خهيبؼًث خَربمي )30.0%  ,00.3%  ٔ
3..6% ) خٚدٔذنا حذئاشنأ وذنا ٙفُٗصلاأ نا ٕ٘ؼًنا ىسنبث غٚزغزنا ذُػ خجسَ ٗهػأ ذَبك بًُٛث ٙنإزنا ٗهػ ٘زشػ وبخ حرازحنبث ذثبضنا ٕ٘ؼًنا ىسنا ٔ
 بٛئشع ٗمًُنا خٚدٔذنا حذئاشهن خٛطبخًنا خغسَلأا ٙف( ٙنإزنا ٗهػ ذَبك ٙزنأ70.0( )%74.7.)%بيأ خًٛؼهجنا بٚلاخنا حزغْ ظٛجضر ربجزخا  ذُٛث ذمف
( بٛئشع ٗمًُنا حرازحنبث ذثبضنا ٕ٘ؼًنا ىسنا واذخزسا ذُػ ذَبك  ظٛجضر خجسَ زجكا ٌا خسارذنا17.1 ,%74.6 ٔ %70.0 ٙف )%ٔ وذنا خٛطبخًنا خغسَلأا
 )٘زشػ ُٙصلأأ خٚدٔذنا حذئاشنا((حزطٛسنا خهيبؼًث خَربمي%82.0 ,%79.5  ٔ%79.5.) 
جاتنتسلاا : ٔ وبخنا خٕٚؼًنا وًٕسهن  .وذنأ خٛطبخًنا خغسَلأا ٙف خٕٚهخنا خٛػبًُنا خثبغزسلأا شٛفحزن حذٛع خٛهثبل  بٛئشع حبمًُنا 
ثاٍصىتلا:   اذًٛٓر  بئٚشع ٗمًُنا ٕ٘ؼًنا ىسهن ميبح ء٘شع زٛضحر خنٔبحيّياذخزسلا  بٚززكث ذض ػبمهكEnterotoxigenic E.coli. 
ثحبلا ثادرفم: ضٛجنا بٚلاخنا حزغْ ظٛجضر ميبؼئ ٙئبزنا ٘زْشنا مٛكشزنا ,وبخنا ٕ٘ؼًنا ىسنا ,حرازحنبث ذثبضنا ٕ٘ؼًنا ىسنا . 
 
Abstract:  
Objectives :This study was aimed to investigate the ability of Enterotoxigenic E.coli and their enterotoxins to 
induce cellular immune response by means of erythrocyte-rosette formation and leukocyte migration inhibition 
factor tests.  
Methods: Total of 30 stool sample was collected from patient with severe diarrhea whom attended to Al-Sadder 
teaching hospital in Al-Najaf city in period extended from April to June  2013. All bacterial isolates was identified 
according to morphological and biochemical testes and by API 20 E system, which further conformational tested for 
heat stable enterotoxin production by Suckling Mice Assay (SMA). three antigens (heat killed bacterial cell, crude 
enterotoxin and purified heat stable enterotoxin ETECST) was prepared and  injected in experimental 
animals(rabbit) and tested in the level of systemic and mucosa (appendix and duodenum). Statistical analysis was 
done by least significant difference (LSD).   
Results: The results showed that 20% (6 isolates) was Enterotoxigenic E.coli  and the immune experiments showed 
significant increase level of E-rosette formation in rabbit injected with heat killed antigen (50.1%, 49.7% and 
53.0%) compared with control (23.1%, 31.8% and 29.6%) in blood appendix and duodenum consecutively, while 
high level appeared in crude enterotoxin and ETECST in appendix (41.3%) and (47.4%) consecutively. The 
assessment of ETECST LIF in migration percent to sensitizer was showing high significant LIF (54.5%, 47.6% and 
43.3%) compared with control (82.0%, 79.5% and 79.5%) in blood appendix and duodenum consecutively. 
Conclusions: crud and partially purified enterotoxins have ability to induce cellular immune response in blood and 
mucosa.   
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Recommendation: prepare a carrier molecule model for partially purified enterotoxins to make a vaccine against 
Enterotoxigenic E.coli .    
Key words: Enterotoxigenic E.coli, crudenterotoxin, partially purified enterotoxins erythrocyte-rosette 
formation and leukocyte migration inhibition factor. 
 
INTRODUCTION: 
Since Enterotoxigenic E.coli is still the most common cause of diarrhoea in the developing world 
resulting in approximately 20 percent of all diarrhoeal episodes in children in these areas, and the 
most frequent cause of diarrhoea in travelers 
(1)
.  
strains ETEC colonize the small intestine, where they produce one or both of two enterotoxins 
called heat labile (LT) and heat stable (ST). Both toxins act by changing the net fluid transport 
activity in the gut from absorption to secretion. LT is structurally similar to cholera toxin and 
activates the adenylate cyclase–cyclic adenosine monophosphate system, whereas ST works on 
guanylate cyclase. The intestinal mucosa is not visibly damaged, the watery stool does not 
contain white or red blood cells, and no inflammatory process occurs in the gut wall. Gut cells 
activated by LT or cholera toxin remain in that state until they die, whereas the effects of ST on 
guanylate cyclase are turned off when the toxin is washed away from the cell
(2)
.  
The immunity in the small intestine was of prime importance for preventing disease. 
Hence, efforts in our laboratory to develop effective vaccines against cholera and ETEC 
diarrhoea have been focused on the identification of major protective antigens preventing 
binding of the bacteria in the intestine, suitable toxoids and optimal ways of inducing intestinal 
immune responses.Hence, immune responses to ST are not induced after infection with ST 
producing ETEC
(3)
.  
Heat-stable enterotoxins are low-molecular-weight, heat-stable, none or weak antigen 
proteins which do not cause intestinal secretion by activation of adenylate cyclase. Based on the 
detailed elucidation of the pathogenic mechanisms of cholera and ETEC, the protection against 
the causative organisms should be directed not only against colonization of the bacteria, but also 
against the toxin action. At least two types have been described, one with biological activity in 
suckling mice and piglets (STa, or named as STh, or ST-I) due to stimulation of particulate 
intestinal guanylate cyclase and a second which induces secretion by an unknown mechanism 
only in piglets (STb, or known as STp, or ST-II). Two partially cross-reacting antigenic variants 
of plasmid-coded LT, designated LTh and LTp, have been described in E. coli. LTh is associated 
with E. coli isolates from humans, and LTp is associated with E. coli isolates from pigs. The LT 
family from restricted geographical region exhibited a segregated pattern of dissemination that 
was revealed by a restriction enzyme site polymorphism
(4)
. 
LT from E. coli is a protein of approximately 86,000 daltons that consists of one A 
polypeptide and five B polypeptides held together by noncovalent   bonds.LT is closely related 
to cholera enterotoxin (CT) in structure, antigenicity, and mode of action. Both LT and CT bind 
to ganglioside GM1 receptors on eukaryotic target cells via their B subunits. The pathway used 
by LT within the host cell is similar to that used by other AB5 toxins like CT 
(5).
 
The aim of study is to investigate the ability of Enterotoxigenic E.coli and their 
enterotoxins to induce cellular immune response and achieved by the following objectives: 
1-Erythrocyte-rosette formation test.  
2- leukocyte migration inhibition factor test. 
METHODOLOGY: 
Isolation and Identification: Total of 30 stool sample was collected from patient with severe 
diarrhea whom attended to Al-Sadder teaching hospital in Al-Najaf city Identification of E.coli 
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isolates were to the level of species using the traditional morphological and biochemical tests, 
according to the methods of 
(6)(7)
.all isolates were confirmed identification with API 20 E system.  
Experimental animals: New born albino mice (1-4) days used in Suckling mice assay (SMT). 
Wild type rabbit (1.5-2) kg used in immune experiment.  
Enterotoxin Assays: Suckling Mice Assay (SMA)Test using infant mice is a convenient assay 
for ST enterotoxin. Supernatants of cultures (0.1 ml) injected with hypodermic needle (no. 30) 
into the milk-filled stomachs of infant mice (1-4) day old and weigh (0.9-1.3) g, the fluid 
accumulation in the intestine was measured after 4 h by determining the ratio of intestine to 
whole body weight. Usually two drops of a 2% solution of food dye were added to each 1 ml of 
inoculums. A ratio ≥ 0.08 was considered positive for heat stable enterotoxin(6).  
Enterotoxigenic E.coli Partially purification of heat stable enterotoxin: The Sephacryl S-
1000 gel was prepared by homogenizing it with Tris-HCl then settled and excess of buffer was 
removed .This step was repeated several times The gel was carefully poured into column 
(0.7×50) cm, down the wall to avoid accumulation of air bubble into it, the gel was left for few 
time to settle, the column outlet was opened .The packing continued to reach the length 36 cm. 
Later the packing gel was equilibrated with tris buffer pH 8. Using a flow rate of 3ml/45min , 
3ml for each fraction were collected by using fraction collector and the absorbencies were 
measured at 280nm by spectrometer, and the peak fraction that showed enterotoxin activity was 
collected and concentrated by dialysis against poly ethylene glycol for further tests
(7)
. 
Heat killed bacterial Antigen:was prepared according to
(8)
. 
Immunization Protocol for Crude Enterotoxin and ETECST: Three adult rabbits were 
immunized intramuscularly with 100 µg of crude enterotoxin and another three rabbits with 
ETECST, for each of the two groups an equal volume of Freund‟s incomplete adjuvant were 
used. Two booster injections were given at weekly intervals. In the fifth week the animal was 
sacrificed after anesthetized by chloroform
(9)
. Then blood and mucosal sampling were done 
according to the following: 
Systemic Blood Sampling :From each rabbit, a blood sample of 7-8 ml was drawn aseptically 
by heart puncture in a disposable syringe. 2.5ml of the blood sample were left at room 
temperature till being clotted, and then centrifuged at 3000 rpm for 5min. The sera were 
aspirated from whole blood and saved in test tube at -20°C till testing time
(4)
.  
Enteromucosal Sampling (Appendix and Duodenum):From each rabbit, 10-12cm from 
appendix and duodenum were collected in an aseptically method. The appendix and duodenum 
were opened by using sterile and clean scissor. The digested material was removed by washing 
them with normal saline. The mucosa and submucosa were scraped by sterile surgical scalpel 
and placed in another sterile petridishe containing 10 ml of normal saline. By sterile pasture 
pipette the suspension was transferred to sterile plastic test tube and shacked by vortex for 5min. 
The suspension was centrifuged at 4000 rpm for 20min. supernatant was ignored and the 
precipitate was washed three times with normal saline and preserved in at ratio 1:1 in Alsever's 
solution for studying NBT test 
(7)
. 
Lymphocyte Suspension Preparation:Two ml of heparinized blood or mucosal suspension was 
gently mixed with 4ml of Hepes-BSS. The diluted blood was carefully added to the 2ml of 
lymphoprep, alongside the inner edge of the tube.The mixture above was centrifuged at 4000rpm 
for 15min.The leukocytes at the interface were aspirated by pasture pipette and washed twice in 
Hepes-BSS then suspended in the same buffer
(4)
. 
Erythrocyte-rosette formation Test: The E-rosette test was done according to the method of 
(10)
. Sheep red blood cells (sRBC) was stored at 4°C in Alsever's solution and used for 1 week. 
Before use, the cell were washed twice and adjusted to a 5% suspension in N.S. The sRBC cell 
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suspension (0.25ml) was mixed with (0.25 ml) of lymphocyte suspension and incubated at 37°C 
for 15min. The mixed cell suspension was spun at 1000 rpm for 5min. and then incubated 
overnight at 4°C. The supernatant fluid was removed, and the top layer of the pellet was gently 
resuspended by shaking. One drop of the cell suspension was mounted on to a glass slide, 
covered by cover slip. Two hundred lymphocytes were counted, and all of the lymphocytes 
binding more than 3 sRBC were considered positive. Same method was used to detect E-rosette 
formation of mucosal lymphocytes. 
Leukocyte Migration Inhibition Factor (LIF): Measurement of migration inhibition factor 
was done according 
(11)
, as follow: Agar-A medium was prepared in a sterile plastic plate 
(2%agar), and two well were done with 2cm in diameter on plate of agar. Capillary tubes filled 
with systemic blood or mucosal suspension was put in each well after centrifugation by 
hematocrite  centrifuge for 10 min. Eagle basal medium (0.1ml) was put in each well; one of 
these wells was considered as control. 0.1 ml of each E.coli antigens prepared in this study was 
added in one well. Incubate at 37°C for 24hr in humid environment. Measurements of LIF by 
oculometer, same steps were used for control and normal saline was added instead of antigen 
sample. LIF was measured from the following equation: 
LIF =  
                        
                           
     
Statistical Analysis : Analysis of variance (ANOVA) and the least significant difference (LSD) 
were used for the statistical analysis of the results and P-values at levels (P<0.05) were 
considered to be statistically significant. These calculations were carried out according to 
program SPSS, version 14.  
RESULTS: 
Erythrocyte-rosette formation test (E-rosette test):  
Table (1) E-rosette test for Enterotoxigenic E.coli antigens on systemic cellular immune 
response in Rabbit  
Antigen Mean  ± SD 
Killed antigen 50.1 ± 1.9 
Crude enterotoxin 31.7 ± 1.4 
ETECST 39.6 ± 1.8 
Control 23.1 ± 1.9 
LSD (0.05) = 1.729 
Table (1) show significant increase level of killed antigen in E-rosette test (50.1) compared 
with control treatment (23.1) on systemic cellular immune response.  
 
Table (2) E-rosette test for Enterotoxigenic E.coli antigens on mucosal (Appendix) cellular 
immune response in Rabbit 
Antigen Mean  ± SD 
Killed antigen 49.7 ± 1.3 
Crude enterotoxin 41.3 ± 0.8 
ETECST 47.4 ± 1.4 
Control 31.8 ± 1.5 
  LSD (0.05) = 1.258 
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Table (2) show significant increase level of ETECST in E-rosette test (47.4) compared 
with control treatment (31.8) on mucosal (Appendix) cellular immune response 
 
Table (3) E-rosette test for Enterotoxigenic E.coli antigens on mucosal (Duodenum) cellular 
immune response in Rabbit 
Antigen Mean  ± SD 
Killed antigen 53.0 ± 1.6 
Crude enterotoxin 39.3 ± 2.0 
ETECST 44.0 ± 1.8 
Control 29.6 ± 1.8 
LSD (0.05) = 1.751 
Table (3) show significant increase level of Killed antigen in E-rosette test (53.0) 
compared with control treatment (29.6) on mucosal (Duodenum) cellular immune response. 
 
The formation of E-rosette in mucosal sample is higher than of systemic except for 
systemic killed antigen (50.1) which higher than of appendix (49.7) and lower than of duodenum 
(53.0).while the partially purified enterotoxin show the high level of E-rosette formation in 
appendix (47.4) then in duodenum (44.4) and in systemic (39.6). The crud enterotoxin showed 
low level of e-rosette formation (31.7, 41.3 and 39.3) in systemic, appendix and duodenum 
consecutively. All result were statistically significant at (p<0.05) compared with control (23.1, 
31.8 and 29.6) in systemic, appendix and duodenum consecutively, tables (1), (2) and (3).  
 
Leukocyte migration inhibitory factor (LIF) test:    
Table (4) LIF test for Enterotoxigenic E.coli antigens on systemic cellular immune response 
in Rabbit 
Antigen Mean  ± SD 
Killed antigen 71.3 ± 1.7 
Crude enterotoxin 66.1 ± 1.3 
ETECST 54.5 ± 1.8 
Control 82.0 ± 1.7 
LSD (0.05) = 2.044 
Table (4) show significant increase level of ETECST in LIF test (54.5) compared with 
control treatment (82.0) on systemic cellular immune response. 
Table ( 5) LIF test for Enterotoxigenic E.coli antigens on mucosal (Appendix) cellular 
immune response in Rabbit 
Antigen Mean  ± SD 
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Killed antigen 57.5 ± 0.5 
Crude enterotoxin 52.6 ± 0.8 
ETECST 47.6 ± 0.8 
Control 79.5 ± 3.0 
LSD (0.05) = 1.972 
Table (5) show significant increase level of ETECST in LIF test (47.6) compared with 
control treatment (79.5) on mucosal (Appendix) cellular immune response. 
Table (6) LIF test for Enterotoxigenic E.coli antigens on mucosal (Duodenum) cellular 
immune response in Rabbit 
Antigen Mean  ± SD 
Killed antigen 56.1 ± 1.1 
Crude enterotoxin 54.6 ± 1.5 
ETECST 43.3 ± 1.6 
Control 79.5 ± 2.9 
LSD (0.05) = 2.332 
Table (6) show significant increase level of ETECST in LIF test (43.3) compared with 
control treatment (79.5) on mucosal (Duodenum) cellular immune response. 
 
The assessment of mucosal LIF in migration percent to sensitizer was showing high significant 
LIF than systemic LIF, were the partially purified heat stable enterotoxin show the high level of 
Leukocyte migration inhibitory factor (54.5, 47.6 and 43.3) for systemic, appendix and 
duodenum consecutively, then crude enterotoxin with means (66.1, 52.6 and 54.6) for systemic, 
appendix and duodenum consecutively and the lower level of inhibition appear in killed antigen 
treatment (71.3, 57.5 and 56.1) for systemic, appendix and duodenum consecutively. All result 
were statistically significant at (p<0.05) compared with control (82.0, 79.5 and 79.5) in systemic, 
appendix and duodenum consecutively, tables (4), (5) and (6). 
DISCUSSION 
Erythrocyte-rosette Formation Test (E-rosette Test) 
As known most T-lymphocytes have receptors for sheep erythrocytes (CD2) on their surface and 
can form 'rosettes' with them to identifying T-cells in mixed lymphocytes population. Leukocyte 
functional antigen-3 (LFA-3 now called CD58) is the surface molecule of sheep RBC that bind 
to (CD2) of T-lymphocytes 
(12)
. The results showed that the formation of E-rosette in mucosal 
samples were higher than of systemic except for systemic killed antigen which induce E-rosette 
formation higher than of appendix and lower than of duodenum, while the ETECST showed the 
high level of E-rosette formation in appendix then in duodenum and in systemic. The crud 
enterotoxin showed low levels of E-rosette formation in systemic, appendix and duodenum 
consecutively. All results were statistically significant at (p<0.05) when compared with control 
tables (1), (2) and (3). These results consists with 
(13)
, who found that Shigella dysenteriae 
exotoxine was able to increase the number of T-lymphocyte due to formation of Erosette at 
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systemic and mucosal levels, and the mean values of mucosal were higher than that of systemic. 
Furthermore 
(8)
 reported that three different antigens of E.coli (outer membrane proteins, 
lipopolysaccharied and killed antigen) have the ability to significantly increase the levelof E-
rosette formation compared with control. Effective immune defense requires CD4 T cells 
(14)
. 
IFN-γ and TNF-α, which regulate T cell growth and differentiation and the recruitment and 
activation of inflammatory cells, respectively, which were involved in adaptive host defense 
against C. rodentium 
(15)
. IL-12 and IFN-γ knockout mice significantly more susceptible to 
mucosal and gut-derived systemic C. rodentium infection. Analysis of the gut mucosa of IL-12 
knockout mice revealed an influx of CD4-T cells and a local IFN-γ response. While IL-12 
Critical cytokine for Th1 differentiation; induces proliferation and IFN-γ production by Th1 (16). 
Heat stable enterotoxin may either form aggregates with other proteins or pigments or remain 
cell associated 
(17)
. As illustrated in table (4) the crude enterotoxin showed very high level of 
lymphocyte activation (lymphocytosis) but not for E-rosette formation. However the CD2 
marker may be blocked by heat-label particles preventing it from binding to its ligand on the 
sheep erythrocytes ''leucocytes functional antigen- 3'' (LFA-3) ,or adsorbed and bind sheep 
erythrocytes preventing them from binding to their receptors on T-cells. 
Leukocyte Migration Inhibitory Factor (LIF) Test: Migration inhibitory factor (MIF) is 
considered to be the first lymphokine activity to be described. The simultaneous original 
descriptions by 
(18,19)
 were of a soluble factor purified from supernatants of activated 
lymphocytes that inhibited the random migration of guinea pig peritoneal macrophages. MIF was 
„rediscovered‟ in the early 1990s as a cytokine/hormone released from the anterior pituitary in 
response to endotoxemia 
(20,21)
 found that MIF is stored preformed in significant quantities in 
human circulating granulocytes ''eosinophils''. In physiological stimulate, C5a and IL-5 cause 
significant release of MIF by eosinophils. The mucosal LIF was showing high significant levels 
than systemic, the ETECST showed the high level of Leukocyte migration inhibitory factor then 
crude enterotoxin and the lower level of inhibition appeared in killed antigen treatment. All 
result were statistically significant at (p<0.05) compared with control. Tables (4), (5) and (6). 
E.coli killed antigen showed significant level of LIF compared with control. Exotoxin of Shigella 
dysenteriae have the ability to induce specific cellular immunity at mucosal and systemic levels 
(13,8)
. The significant decrease to more than 30% inhibition in index mean values of LIF at 
mucosal system may refer containing higher number of activated T-cell
(22) Importantly, however, 
the clearance of intra tracheal administered Gram-negative pathogens was not only preserved, 
but slightly enhanced in MIF knockout mice. Plasma levels of the critical mediator, tumor 
necrosis factor α (TNFα), were lower in MIF knockout mice than in controls in response to 
septic insults 
(23)
. The reduction of LIF with ETECST may be accordance with not full 
purification of toxin, where, Due to its small size, ST is nonimmunogenic in its natural form but 
becomes immunogenic when coupled to an appropriate large-molecular-weight carrier 
(24)
. This 
has been successfully achieved with several carriers such as (B-subunit of LT, porcine IgG, B-
sub unit of CT, ZZ moiety derived from Staphylococcus aureus protein A, Flagellin and porcine 
LT) were lost its toxicity and gain its specific immunogenicity 
(9)
. 
CONCLUSIONS 
Crud and partially purified enterotoxins have ability to induce cellular immune response in blood 
and mucosa.   
 
RECOMMENDATION:  
1-Prepare a carrier molecule model for partially purified enterotoxins  
2-Make a vaccine against Enterotoxigenic E.coli toxins. 
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